Based on our results of IHC staining of CA IX, we can conclude that the diagnostic ability of MAb IV/18 is reliable, as it specifically detects all subcellular forms of CA IX protein in early breast cancer tissue. The gene discussed is CA9; the disease is breast carcinoma.